Home / Resource Library / Real-World Adverse Events Associated with Tisagenlecleucel in Acute Lymphoblastic Leukemia and Large B-Cell Lymphoma

Real-World Adverse Events Associated with Tisagenlecleucel in Acute Lymphoblastic Leukemia and Large B-Cell Lymphoma

ASH 2020: Study investigated the safety of CAR T therapy Tisagenlecleucel for treatment of relapsed diffuse large b cell lymphoma.